-
Diagnostics World | It may be possible one day soon to prevent Alzheimer’s disease, a devastating illness currently suffered by more than 30 million people worldwide. The good news comes straight from the mouth of Randall J. Bateman, M.D., professor of neurology at Washington University School of Medicine and director of the Dominantly Inherited Alzheimer Network (DIAN) and DIAN Trials Unit (DIAN-TU).
Nov 8, 2023
-
Diagnostics World | Mayo Clinic and Oxford Nanopore Technologies teams up in a multi-year joint development collaboration to help improve patient care, including some of the hardest-to-characterize conditions and sequencing DNA; Walgreens and the Cardiovascular Research Foundation (CRF) collaborates to drive the PREVUE-VALVE study, which will help pave the way for the development of new therapies and tools for VHD detection and diagnosis; Genialis announces a new data-sharing collaboration with Cancer Research Horizons to better predict responses to KRAS inhibitors, immunotherapies, and other emerging classes of therapeutics; and more.
Nov 7, 2023
-
Diagnostics World | A private biomedical engineering and biomarker research lab in Canada has succeeded in measuring what type 2 diabetes does to the body as manifested through the voice and it is “opening a new lens” to the identification of at-risk individuals and potentially the assessment of therapeutic interventions.
Nov 2, 2023
-
Diagnostics World | Researchers at the University of Western Ontario and Brown University were surprised to discover an “almost identical mechanism” appearing in the blood and placenta of women with preeclampsia as has been previously found in the brains of older individuals with Alzheimer’s disease (AD), traumatic brain injury (TBI), and vascular dementia.
Nov 1, 2023
-
Diagnostics World | Researchers at Dana-Farber Cancer Institute and Massachusetts Institute of Technology have developed a new tool, based on artificial intelligence, that predicts the likely site of formation for cancer of unknown primary (CUP) tumors.
Oct 31, 2023
-
Diagnostics World | Mayo Clinic and Oxford Nanopore Technologies teams up in a multi-year joint development collaboration to help improve patient care, including some of the hardest-to-characterize conditions and sequencing DNA; Walgreens and the Cardiovascular Research Foundation (CRF) collaborates to drive the PREVUE-VALVE study, which will help pave the way for the development of new therapies and tools for VHD detection and diagnosis; Genialis announces a new data-sharing collaboration with Cancer Research Horizons to better predict responses to KRAS inhibitors, immunotherapies, and other emerging classes of therapeutics; and more.
Oct 26, 2023
-
Diagnostics World | bioMérieux further invests in Oxford Nanopore to expand in vitro diagnostics production; Harbinger Health trials blood-based cancer screening platform; HHS funds behavioral health services and HIV prevention for underserved populations; and more.
Oct 25, 2023
-
Diagnostics World | A group of researchers at the University of California Santa Cruz, University of Arizona, and University of Illinois at Chicago have identified a candidate biomarker that may help lead to earlier detection of ovarian cancer without the need for a biopsy. They hope that gynecologists could someday look for the presence of this biomarker while performing a routine Pap smear, but additional research involving more patients is still needed.
Oct 18, 2023
-
Diagnostics World | The rise and fall of blood protein levels over time is an astonishingly good way to assess the risk of major atherosclerotic cardiovascular disease (ASCVD) events such as myocardial infarction (heart attack), as well as an ideal biomarker of the progression of disease and its regression in response to treatment
Oct 17, 2023
-
Diagnostics World | The European Commission (EC), under the EU Merger Regulation (EUMR), released a statement last week announcing it has taken restorative measures that require Illumina to unwind its acquisition of GRAIL. The acquisition was completed before the EC provided approval, breaching EU merger control rules.
Oct 16, 2023
-
Diagnostics World | The laboratory side of diagnostic blood testing has achieved extraordinary efficiency and precision through automation. The last few decades of technology have allowed labs to simplify and automate sample processing to streamline operations and remove opportunities for human error.
Oct 13, 2023
-
Diagnostics World | The feasibility and design of a randomized controlled trial (RCT) for evaluating multi-cancer detection (MCD) assays suited to population-based cancer screening is the aim of a pilot Vanguard Study being undertaken by the National Cancer Institute (NCI).
Oct 10, 2023
-
Diagnostics World | Beginning today, the research team at Children’s Mercy Kansas City is bringing long read sequencing to clinical care, following three years of research and testing of PacBio HiFi sequencing. The transition is expected to speed the diagnostics odyssey for critically ill patients and their families.
Oct 6, 2023
-
Diagnostics World | Soon it may be possible for people to walk into their doctor’s office anywhere in the world and learn from a fingerprick blood sample if they are genetically predisposed to developing osteoporosis. It will matter not if those individuals are anywhere near the age of menopause, or if they’re male or female, because the SNPs being measured were present from the day they were born and men are by no means immune to the condition.
Oct 4, 2023
-
Diagnostics World | Over 900 genes have been implicated in the resistance of tumors to platinum-based chemotherapy that map to many different cellular pathways, thwarting efforts to identify a biomarker to predict refractoriness.
Oct 3, 2023
-
Diagnostics World | Paige and Microsoft aim to build the world’s largest image-based AI models for digital pathology and oncology; the GA4GH Board of Directors has elected Heidi Rehm to succeed Ewan Birney; The U.S. Department of Health and Human Services (HHS) announced new details of its agreement with Regeneron to extend its public-private partnership to develop life-saving monoclonal antibodies as part of Project NextGen enhancing our preparedness for COVID-19 strains and variants; and more.
Sep 28, 2023
-
Diagnostics World | Moderna and Immatics launch a strategic research and development collaboration to pioneer novel and transformative therapies for cancer patients with high unmet medical need; Generate:Biomedicines secures huge funding to advance its AI platform; Ibex Medical Analysis’ Galen platform transforms cancer diagnostics with AI; more.
Sep 27, 2023
-
Diagnostics World | Digital anatomic pathology allows for several potential benefits in clinical research, from speedier and traceable processes to improved consistency in visualisations and assessment outcomes.
Sep 22, 2023
-
Diagnostics World | Uncertainty surrounds the reimbursement landscape for multiplex testing and mandates and guidance issued as part of the COVID-19 public health emergency (PHE) only added a fresh dose of complications.
Sep 20, 2023
-
Diagnostics World | Researchers in the U.S. and Sweden have identified a biomarker (MTBR-tau243) for Alzheimer’s disease that tracks with the amount of damaging tau tangles in the brain and, when combined with a specific phosphorylated tau species (p-tau205), is nearly as predictive of cognitive function as tau-positron emission tomography (tau-PET) imaging.
Sep 19, 2023